Pegylated liposomal doxorubicin and carboplatin in advanced gynecologic tumors: a prospective phase I/II study of the Arbeitsgemeinschaft Gynaekologische Onkologie Studiengruppe Ovarialkarzinom (AGO-OVAR).
about
Lipid-Based Drug Delivery Systems in Cancer Therapy: What Is Available and What Is Yet to Come.Safety of a 3-weekly schedule of carboplatin plus pegylated liposomal doxorubicin as first line chemotherapy in patients with ovarian cancer: preliminary results of the MITO-2 randomized trial.A randomized phase II study of carboplatin plus pegylated liposomal doxorubicin versus carboplatin plus paclitaxel in platinum sensitive ovarian cancer patients: a Hellenic Cooperative Oncology Group study.Pegylated liposomal doxorubicin in the management of ovarian cancerSarcoma of the Uterus. Guideline of the DGGG (S2k-Level, AWMF Registry No. 015/074, August 2015).Are there candidates for high-dose chemotherapy in ovarian carcinoma?Pharmacokinetic and toxicity considerations for the use of anthracyclines in ovarian cancer treatment.Use of pegylated liposomal doxorubicin in the management of platinum-sensitive recurrent ovarian cancer: current concepts.Pegylated liposomal doxorubicin in ovarian cancer.A multicentre phase II study of carboplatin plus pegylated liposomal doxorubicin as first-line chemotherapy for patients with advanced or recurrent endometrial carcinoma: the END-1 study of the MITO (Multicentre Italian Trials in Ovarian Cancer and G
P2860
Q30366990-871A7565-7F8F-4413-B8BB-6D3CE22E2B47Q33372127-7BE4CBA2-9529-4BDD-A0B1-3A96D14F338BQ33387755-E1BDC347-4137-40D7-8CC4-055A106EDD82Q34187661-C6E23CAF-DF66-4DCA-BFE6-DE7C617BF86BQ36295510-84599C83-7FF3-461E-A266-08963CEEDA21Q36468856-0E1F654E-3BB7-47C6-9C25-0EA3B6AB5FC3Q37857281-3DE28ADB-4A3B-483A-9625-CCCFEA97E1CFQ37965631-4422D4B2-9867-42AE-BBEF-D4F8AC5DF3DCQ43065300-01F6DFD9-AB1C-4EB4-A8A9-49CCBC94A0C6Q57903847-23060675-8C81-46EA-8B96-BB47DE51596C
P2860
Pegylated liposomal doxorubicin and carboplatin in advanced gynecologic tumors: a prospective phase I/II study of the Arbeitsgemeinschaft Gynaekologische Onkologie Studiengruppe Ovarialkarzinom (AGO-OVAR).
description
2005 nî lūn-bûn
@nan
2005 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Pegylated liposomal doxorubici ...... pe Ovarialkarzinom (AGO-OVAR).
@ast
Pegylated liposomal doxorubici ...... pe Ovarialkarzinom (AGO-OVAR).
@en
type
label
Pegylated liposomal doxorubici ...... pe Ovarialkarzinom (AGO-OVAR).
@ast
Pegylated liposomal doxorubici ...... pe Ovarialkarzinom (AGO-OVAR).
@en
prefLabel
Pegylated liposomal doxorubici ...... pe Ovarialkarzinom (AGO-OVAR).
@ast
Pegylated liposomal doxorubici ...... pe Ovarialkarzinom (AGO-OVAR).
@en
P2093
P356
P1433
P1476
Pegylated liposomal doxorubici ...... pe Ovarialkarzinom (AGO-OVAR).
@en
P2093
Arbeitsgemeinschaft Gynaekologische Onkologie Studiengruppe Ovarialkarzinom
B Schmalfeldt
C Jackisch
J Pfisterer
P356
10.1093/ANNONC/MDJ032
P577
2005-11-09T00:00:00Z